VBI-1901
Showing 1 - 23 of 23
Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (VBI-1901, Carmustine, Lomustine)
Active, not recruiting
- Glioblastoma Multiforme
- VBI-1901
- +2 more
-
Los Angeles, California
- +3 more
Jun 27, 2022
Diabetic Macular Edema Trial (EYP-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)
Not yet recruiting
- Diabetic Macular Edema
- EYP-1901
- Aflibercept 2Mg/0.05Ml Inj,Oph
- (no location specified)
Oct 19, 2023
Covid19 Trial in Halifax, Ottawa, Toronto (VBI-2902a, Placebo, VBI-2905a)
Active, not recruiting
- Covid19
- VBI-2902a
- +2 more
-
Halifax, Nova Scotia, Canada
- +3 more
Jul 18, 2022
COVID-19, Coronavirus Infections Trial in Halifax, Ottawa, Quebec (VBI-2901e)
Not yet recruiting
- COVID-19
- Coronavirus Infections
- VBI-2901e
-
Halifax, Nova Scotia, Canada
- +3 more
Dec 10, 2022
COVID-19, Coronavirus Infections Trial in Canada (VBI-2901a)
Recruiting
- COVID-19
- Coronavirus Infections
- VBI-2901a
-
Halifax, Nova Scotia, Canada
- +6 more
Nov 16, 2022
Advanced Malignant Tumors Trial in Shanghai (SHR-1901)
Recruiting
- Advanced Malignant Tumors
-
Shanghai, Shanghai, ChinaZhongshan Hospital Affiliated to Fudan University
Feb 11, 2022
Nonproliferative Diabetic Retinopathy Trial (EYP-1901, Sham IVT)
Not yet recruiting
- Nonproliferative Diabetic Retinopathy
- EYP-1901
- Sham IVT
- (no location specified)
Aug 3, 2022
Wet Age-related Macular Degeneration Trial in United States (Eyp-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)
Recruiting
- Wet Age-related Macular Degeneration
- Eyp-1901
- Aflibercept 2Mg/0.05Ml Inj,Oph
-
Melbourne, Florida
- +4 more
Aug 18, 2022
Hepatitis B, Chronic Trial in Worldwide (BRII-835 (VIR-2218), BRII-179 (VBI-2601) with IFN-a, BRII-179 (VBI-2601))
Active, not recruiting
- Hepatitis B, Chronic
- BRII-835 (VIR-2218)
- +2 more
-
Kingswood, New South Wales, Australia
- +27 more
Mar 1, 2022
Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in Vancouver, Ottawa (CLIC-1901)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- CLIC-1901
-
Vancouver, British Columbia, Canada
- +1 more
Mar 26, 2022
Drug Drug Interaction Trial in Hachioji-shi (SyB V-1901, Cyclosporine)
Completed
- Drug Drug Interaction
- SyB V-1901
- Cyclosporine
-
Hachioji-shi, Tokyo, JapanResearch Site
Apr 25, 2021
Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH
Recruiting
- Chronic Graft-versus-Host-Disease
- +4 more
-
San Francisco, California
- +15 more
Jun 17, 2022
Cytomegalovirus Infections Trial in Vancouver, Halifax, Pierrefonds (VBI-1501A 0.5 µg, VBI-1501A 1.0 µg, VBI-1501A 2.0 µg)
Completed
- Cytomegalovirus Infections
- VBI-1501A 0.5 μg
- +4 more
-
Vancouver, British Columbia, Canada
- +2 more
Apr 16, 2020
Acute Respiratory Distress Syndrome, Covid19 Trial in Ottawa (Mesenchymal Stromal Cells)
Completed
- Acute Respiratory Distress Syndrome
- Covid19
- Mesenchymal Stromal Cells
-
Ottawa, Ontario, CanadaThe Ottawa Hospital
Apr 23, 2021
Stroke, Silent Cerebral Infarction, Neurocognitive Dysfunction Trial in London (CO2 flushing, Saline flushing)
Unknown status
- Stroke
- +3 more
- CO2 flushing
- Saline flushing
-
London, United KingdomImperial College London
May 8, 2019
Biliary Colic Trial (transvaginal cholecystectomy, laparoscopic cholecystectomy)
Completed
- Biliary Colic
- transvaginal cholecystectomy
- laparoscopic cholecystectomy
- (no location specified)
Jan 12, 2018
Alcohol Consumption, Violence, Facial Injuries Trial in Glasgow (Violence Brief Intervention, ABI)
Unknown status
- Alcohol Consumption
- +2 more
- Violence Brief Intervention
- ABI
-
Glasgow, United KingdomDepartment of Oral and Maxillofacial Surgery, Southern General H
Mar 30, 2015
Symptomatic Ostial Vertebral Artery Stenosis Treated With
Unknown status
- Vertebral Artery Stenosis
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 14, 2005